Quarterly report · Q2
2927.TEDINET S100QLNK
Period2022-09-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.4bn | 2022-09-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥23.0bn | 2021-09-01 → 2022-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.2bn | 2021-09-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | ¥678m | 2022-09-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥453m | 2021-09-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | ¥708m | 2022-09-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-09-01 → 2022-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥643m | 2021-09-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥616m | 2022-09-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥560m | 2021-09-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥414m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥735m | 2021-09-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥307m | 2021-09-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥417m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥307m | 2021-09-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥39.0bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥37.3bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥35.9bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥26.3bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥24.9bn | at 2022-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥12.6bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥12.4bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.9bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.4bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.8bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2022-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2021-08-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥397m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥314m | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥791m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.2bn | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥924m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2021-09-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥774m | 2021-09-01 → 2022-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥29.46 | 2022-09-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.01 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.33 | 2021-09-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.84 | 2021-09-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.8 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.45 | 2022-09-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥52.08 | 2021-09-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥21.71 | 2021-09-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 32.3% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | revenue external | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | segment profit | 2022-09-01 → 2023-02-28 | −¥2m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥13m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | −¥121m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥940m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥103m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-02-28 | ¥933m |
| Otherother segments | revenue | 2021-09-01 → 2022-02-28 | ¥23m |
| Otherother segments | revenue external | 2021-09-01 → 2022-02-28 | ¥23m |
| Otherother segments | segment profit | 2021-09-01 → 2022-02-28 | −¥10m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥2.3bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥2.3bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2021-09-01 → 2022-02-28 | −¥122m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥441m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥441m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2021-09-01 → 2022-02-28 | −¥190m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥7.6bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥7.6bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥992m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2021-09-01 → 2022-02-28 | ¥871m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2021-09-01 → 2022-02-28 | ¥871m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2021-09-01 → 2022-02-28 | ¥85m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-09-01 → 2022-02-28 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-09-01 → 2022-02-28 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-09-01 → 2022-02-28 | ¥755m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 536
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 2050070 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1457 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 1161930 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0826 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 370400 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0263 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 330400 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0235 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 305000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0217 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 300000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0213 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 131400 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0093 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 129167 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0092 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 124900 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0089 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 114600 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0081 | |
| Number of shares held | CurrentQuarterInstant | 5017867 | |
| Shareholding ratio | CurrentQuarterInstant | 0.3566 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 316000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 14066000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 140660 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 5699 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 14387699 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 140660 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 316000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 316000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0220 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 316000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 316000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0220 | |
| Cash and deposits | Prior1YearInstant | 10377778000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 10905778000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 2578619000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 2753982000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 1529950000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 1660623000 | JPY |
| Work in process | Prior1YearInstant | 834751000 | JPY |
| Work in process | CurrentQuarterInstant | 926582000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 1363303000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 1438013000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |